The Japan Antimicrobial Resistance Study Group1Includes: Toho University School of Medicine (K. Yamaguchi), Tokyo; Tokyo Medical College (K. Chiba), Tokyo; School of Medicine, Kitasato University (M. Inoue), Sagamihara; St. Marianna University School of Medicine (J. Shimada), Kawasaki; Osaka University Hospital (S. Asari), Osaka; Kansai Medical University (H. Heijyo), Osaka; Kawasaki Medical School (T. Matsushima), Kurashiki; Kawasaki Medical School, Kawasaki Hospital (J. Okimoto), Okayama; School of Medicine, Fukuoka University (T. Takada), Fukuoka; Kurume University, School of Medicine (K. Kajimura), Kurume; Nagasaki University, School of Medicine (S. Kohno), Nagasaki; Institute of Tropical Medicine, Nagasaki University (K. Watanabe), Nagasaki; National Sanatorium Nishi–Niigata Chuo Hospital (K. Wada), Niigata; Shinrakuen Hospital (N. Aoki), Niigata; Saiseikai Utsunomiya Hospital (T. Kanno), Utsunomiya; Japanese Foundation for Cancer Research, Cancer Institute Hospital (J. Shiotani), Tokyo; Central Hospital of Social Health Insurance (Y. Otsuka), Tokyo; Kanagawa Prefectural School of Nursing and Hygiene Hospital (F. Matsumoto), Kanagawa; Kanagawa Prefectural Cardiovascular and Respiratory Disease Center (S. Odagiri), Kanagawa; Federation of National Public Service and Affiliated Personnel Mutual Aid Association Otemae Hospital (K. Yamanaka), Osaka; Saiseikai Suita Hospital (S. Inoue), Osaka; Tenri Hospital (M. Aihara), Nara; and School of Medicine, University of the Ryukyus (A. Saito; Observer), Okinawa.,
M. Todd Lewis,
Keizo Yamaguchi,
Douglas J. Biedenbach,
Ronald N. Jones